{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:13:31Z","timestamp":1792800811004,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230487-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Long-term survivors of childhood cancer may be at elevated risk for new neurocognitive impairment and decline as they age into adulthood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230487-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether aging adult childhood cancer survivors report more new-onset neurocognitive impairments compared with their siblings and to identify risk factors associated with such impairments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230487-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Participants of this cohort study included adult survivors of childhood cancer from the Childhood Cancer Survivor Study and their siblings as a control group. The original cohort included survivors who received a diagnosis between January 1, 1970, and December 31, 1986, for whom longitudinal neurocognitive assessment was available. This study examined the prevalence of new-onset neurocognitive impairment between baseline (23.4 years after diagnosis) and follow-up (35.0 years after diagnosis). The analysis was performed from January 2021 to May 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230487-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Cancer treatment exposures were abstracted from medical records. Chronic health conditions were graded using Common Terminology Criteria for Adverse Events version 4.03.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230487-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was new-onset (present at follow-up, but not present at baseline) neurocognitive impairment (defined as a score in the worst 10% of the sibling cohort). Impairment was assessed using the Childhood Cancer Survivor Study Neurocognitive questionnaire. Relative risks (RRs) and 95% CIs were used to estimate associations of neurocognitive impairment with treatment and health behaviors and conditions using generalized linear models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230487-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort comprised 2375 survivors (mean [SD] age at evaluation, 31.8 [7.5] years; 1298 women [54.6%]) of childhood cancer, including acute lymphoblastic leukemia (ALL;\u20091316 participants), central nervous system (CNS) tumors (488 participants), and Hodgkin lymphoma (HL;\u2009571 participants). A total of 232 siblings (mean [SD] age at evaluation, 34.2 [8.4] years; 134 women [57.8%]) were included. Compared with siblings, a higher proportion of survivors with no impairment in memory at baseline had new-onset memory impairment at follow-up: siblings proportion, 7.8% (95% CI, 4.3%-11.4%); ALL survivors treated with chemotherapy only, 14.0% (95% CI, 10.7%-17.4%); ALL survivors treated with cranial radiation (CRT), 25.8% (95% CI, 22.6%-29.0%); CNS tumor survivors, 34.7% (95% CI, 30.0%-39.5%); and HL survivors, 16.6% (95% CI, 13.4%-19.8%). New-onset memory impairment was associated with CRT in CNS tumor survivors (RR,\u20091.97; 95% CI, 1.33-2.90) and alkylator chemotherapy greater than or equal to 8000 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      in ALL survivors treated without CRT (RR,\u20092.80; 95% CI, 1.28-6.12). Neurologic conditions mediated the impact of CRT on new-onset memory impairment in CNS survivors. Smoking, low educational attainment, and low physical activity were associated with elevated risk for new-onset memory impairment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230487-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>These findings suggest that adult survivors of childhood cancer are at elevated risk for late-onset memory impairment related to modifiable risk factors identified early in survivorship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.16077","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T11:33:30Z","timestamp":1685532810000},"page":"e2316077","source":"Crossref","is-referenced-by-count":71,"title":["Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors"],"prefix":"10.1001","volume":"6","author":[{"given":"Nicholas S.","family":"Phillips","sequence":"first","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla L.","family":"Stratton","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnaLynn M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ahles","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten K.","family":"Ness","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey Jay","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Edelstein","sequence":"additional","affiliation":[{"name":"Department of Psychology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Oeffinger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Howell","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics, MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Leisenring","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Krull","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Control Department, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"4","key":"zoi230487r1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1158\/1055-9965.EPI-08-0988","article-title":"Long-term survivors of childhood cancers in the United States.","volume":"18","author":"Mariotto","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"zoi230487r2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","article-title":"Aging and risk of severe, disabling, life-threatening, and fatal events in the Childhood Cancer Survivor Study.","volume":"32","author":"Armstrong","year":"2014","journal-title":"J Clin Oncol"},{"issue":"10112","key":"zoi230487r3","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"zoi230487r4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","article-title":"Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.","volume":"19","author":"Gibson","year":"2018","journal-title":"Lancet Oncol"},{"issue":"21","key":"zoi230487r5","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2017.76.4696","article-title":"Neurocognitive outcomes and interventions in long-term survivors of childhood cancer.","volume":"36","author":"Krull","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi230487r6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1037\/a0016674","article-title":"Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study.","volume":"23","author":"Ellenberg","year":"2009","journal-title":"Neuropsychology"},{"issue":"12","key":"zoi230487r7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jnci\/djq156","article-title":"Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers.","volume":"102","author":"Kadan-Lottick","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"zoi230487r8","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/cncr.v113:8","article-title":"Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire.","volume":"113","author":"Krull","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"zoi230487r9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1037\/neu0000095","article-title":"The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity.","volume":"29","author":"Kenzik","year":"2015","journal-title":"Neuropsychology"},{"issue":"3","key":"zoi230487r10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","article-title":"Subjective cognitive decline and rates of incident Alzheimer\u2019s disease and non-Alzheimer\u2019s disease dementia.","volume":"15","author":"Slot","year":"2019","journal-title":"Alzheimers Dement"},{"key":"zoi230487r11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/clinpsy.2017.13.issue-1","article-title":"Subjective cognitive decline in preclinical Alzheimer\u2019s disease.","volume":"13","author":"Rabin","year":"2017","journal-title":"Annu Rev Clin Psychol"},{"issue":"3","key":"zoi230487r12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","article-title":"The characterisation of subjective cognitive decline.","volume":"19","author":"Jessen","year":"2020","journal-title":"Lancet Neurol"},{"issue":"8","key":"zoi230487r13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.22258","article-title":"Screening for cognitive impairment in older adults: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"323","author":"Patnode","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"zoi230487r14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/pbc.v52:4","article-title":"Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.","volume":"52","author":"Buizer","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"zoi230487r15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.2015.64.3205","article-title":"Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol.","volume":"34","author":"Jacola","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi230487r16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jpepsy\/jsi016","article-title":"Neurocognitive outcomes in survivors of childhood cancer.","volume":"30","author":"Moore","year":"2005","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"zoi230487r17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.apmr.2007.08.123","article-title":"The impact of limitations in physical, executive, and emotional function on health-related quality of life among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.","volume":"89","author":"Ness","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"issue":"15","key":"zoi230487r18","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer.","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi230487r19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jnci\/djx224","article-title":"Chronic health conditions and neurocognitive function in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.","volume":"110","author":"Cheung","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"zoi230487r20","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1182\/blood.2021013167","article-title":"Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma.","volume":"139","author":"Williams","year":"2022","journal-title":"Blood"},{"issue":"3","key":"zoi230487r21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ana.v89.3","article-title":"Childhood neurotoxicity and brain resilience to adverse events during adulthood.","volume":"89","author":"Williams","year":"2021","journal-title":"Ann Neurol"},{"issue":"14","key":"zoi230487r22","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1200\/JCO.2009.22.3339","article-title":"The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.","volume":"27","author":"Robison","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi230487r23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1667\/RR15201.1","article-title":"Adaptations to a generalized radiation dose reconstruction methodology for use in epidemiologic studies: an update from the MD Anderson Late Effect Group.","volume":"192","author":"Howell","year":"2019","journal-title":"Radiat Res"},{"issue":"5","key":"zoi230487r24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jnci\/djaa136","article-title":"Sex-specific associations between chemotherapy, chronic conditions and neurocognitive impairment in acute lymphoblastic leukemia survivors: a report from the Childhood Cancer Survivor Study.","volume":"113","author":"van der Plas","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi230487r26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1037\/1040-3590.18.1.22","article-title":"Factor structure of the Brief Symptom Inventory\u201318 in adult survivors of childhood cancer: results from the Childhood Cancer Survivor Study.","volume":"18","author":"Recklitis","year":"2006","journal-title":"Psychol Assess"},{"issue":"2","key":"zoi230487r27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/1055-9965.EPI-07-2541","article-title":"Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study.","volume":"17","author":"Zeltzer","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"zoi230487r29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.v67.3","article-title":"Neuroanatomical abnormalities related to dexamethasone exposure in survivors of childhood acute lymphoblastic leukemia.","volume":"67","author":"Phillips","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"zoi230487r30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/brain.2017.0574","article-title":"Brain network connectivity and executive function in long-term survivors of childhood acute lymphoblastic leukemia.","volume":"8","author":"Kesler","year":"2018","journal-title":"Brain Connect"},{"issue":"5","key":"zoi230487r31","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000250","article-title":"Biology of premature ageing in survivors of cancer.","volume":"2","author":"Cupit-Link","year":"2017","journal-title":"ESMO Open"},{"key":"zoi230487r33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbacli.2015.01.006","article-title":"Cancer metabolism and oxidative stress: insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate.","volume":"3","author":"Hess","year":"2015","journal-title":"BBA Clin"},{"issue":"7","key":"zoi230487r34","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.freeradbiomed.2007.06.027","article-title":"An epigenetic perspective on the free radical theory of development.","volume":"43","author":"Hitchler","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"zoi230487r35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease.","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol"},{"issue":"10","key":"zoi230487r36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.7326\/M13-2266","article-title":"Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects.","volume":"160","author":"Yeh","year":"2014","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi230487r37","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort.","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi230487r38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/gme.0b013e31822a9937","article-title":"Premature menopause or early menopause and risk of ischemic stroke.","volume":"19","author":"Rocca","year":"2012","journal-title":"Menopause"},{"issue":"12","key":"zoi230487r39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11920-018-0972-1","article-title":"Estrogens, aging, and working memory.","volume":"20","author":"Hampson","year":"2018","journal-title":"Curr Psychiatry Rep"},{"issue":"13","key":"zoi230487r40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jnci\/djj243","article-title":"Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.","volume":"98","author":"Sklar","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi230487r41","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.v124.5","article-title":"Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.","volume":"124","author":"Levine","year":"2018","journal-title":"Cancer"},{"issue":"8","key":"zoi230487r42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25991","article-title":"Longitudinal assessments of neurocognitive performance and brain structure associated with initiation of tobacco use in children, 2016 to 2021.","volume":"5","author":"Dai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi230487r43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1192\/apt.7.1.24","article-title":"Risk factors for dementia.","volume":"7","author":"McCullagh","year":"2001","journal-title":"Adv Psychiatr Treat"},{"issue":"14","key":"zoi230487r44","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1200\/JCO.2008.21.1433","article-title":"Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.","volume":"27","author":"Zeltzer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"zoi230487r45","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/pon.1848","article-title":"Psychological outcomes of siblings of cancer survivors: a report from the Childhood Cancer Survivor Study.","volume":"20","author":"Buchbinder","year":"2011","journal-title":"Psychooncology"},{"issue":"3","key":"zoi230487r46","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s11764-021-01056-0","article-title":"Health-related and cancer risk concerns among siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study (CCSS).","volume":"16","author":"Morales","year":"2022","journal-title":"J Cancer Surviv"},{"key":"zoi230487r32","volume-title":"Elements of Radiobiology","author":"Selman","year":"1983"},{"key":"zoi230487r25","unstructured":"St Jude Children\u2019s Research Hospital. CCSS: the Childhood Cancer Survivor Study\u2014questionnaires. Accessed April 19, 2023. https:\/\/ccss.stjude.org\/tools-documents\/questionnaires.html"},{"key":"zoi230487r28","unstructured":"National Academies of Sciences, Engineering, and Medicine. Social isolation and loneliness in older adults: opportunities for the health care system. 2020. Accessed April 20, 2023. https:\/\/nap.nationalacademies.org\/catalog\/25663\/social-isolation-and-loneliness-in-older-adults-opportunities-for-the"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805444\/phillips_2023_oi_230487_1684514524.04251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T11:33:34Z","timestamp":1685532814000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.16077","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}